2 results
Approved WMOWill not start
Primary ObjectiveTo evaluate the preliminary safety and tolerability and the preliminary efficacy of cobimetinib administered as single agent (Arm A), cobimetinib + venetoclax (Arm B), and cobimetinib + venetoclax + atezolizumab (Arm C)Secondary…
Approved WMOPending
1. To evaluate the feasibility of cryoballoon therapy in patients with incurable esophageal carcinoma and symptoms of dysphagia, defined as technical success rate. In addition, the efficacy and safety will be assessed by looking at the clinical…